Dynamic contrast-enhanced MRI in patients with luminal Crohn's disease  by Ziech, M.L.W. et al.
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Objectives:  To  prospectively  assess  dynamic  contrast-enhanced  (DCE-)MRI  as  compared  to  conventional
sequences  in  patients  with  luminal  Crohn’s  disease.
Methods:  Patients  with  Crohn’s  disease  undergoing  MRI  and  ileocolonoscopy  within  1 month  had  DCE-
MRI  (3T)  during  intravenous  contrast  injection  of gadobutrol,  single  shot  fast  spin  echo  sequence  and  3D
T1-weighted  spoiled  gradient  echo  sequence,  a dynamic  coronal  3D  T1-weighted  fast spoiled  gradient
were  performed  before  and  after  gadobutrol.  Maximum  enhancement  (ME)  and initial  slope of  increase
(ISI)  were  calculated  for four  colon  segments  (ascending  colon  + coecum,  transverse  colon,  descending
colon  + sigmoid,  rectum)  and  (neo)terminal  ileum.  C-reactive  protein  (CRP),  Crohn’s  disease  activity  index
(CDAI),  per  patient  and per  segment  Crohn’s  disease  endoscopic  index  of severity  (CDEIS)  and  disease
duration  were  determined.  Mean  values  of the (DCE-)MRI  parameters  in  each  segment  from  each patient
were compared  between  four  disease  activity  groups  (normal  mucosa,  non-ulcerative  lesions,  mild  ulcer-
ative  and  severe  ulcerative  disease)  with  Mann–Whitney  test  with  Bonferroni  adjustment.  Spearman
correlation  coefﬁcients  were  calculated  for continuous  variables.
Results:  Thirty-three  patients  were  included  (mean  age 37  years;  23  females,  median  CDEIS  4.4).  ME
and ISI correlated  weakly  with  segmental  CDEIS  (r  =  0.485  and  r =  0.206)  and  ME  per  patient  correlated
moderately  with  CDEIS  (r =  0.551).  ME was  signiﬁcantly  higher  in segments  with  mild  (0.378)  or  severe
(0.388)  ulcerative  disease  compared  to normal  mucosa  (0.304)  (p <  0.001).  No  ulcerations  were  identiﬁed
at conventional  sequences.  ME  correlated  with  disease  duration  in  diseased  segments  (r  = 0.492),  not  with
CDAI and  CRP.
Conclusions:  DCE-MRI  can be used  as  a method  for  detecting  Crohn’s  disease  ulcerative  lesions.. Introduction
Grading of severity of disease activity is important in patients
ith Crohn’s disease to optimally determine the treatment strat-
gy and response to treatment. Because clinical and laboratory
arameters do not represent disease activity well, other methods
re used such as ileocolonoscopy and magnetic resonance imaging
MRI). A meta-analysis established that MRI  was  91% accurate
n detecting severe disease but only 62% in patients with mild
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disease or remission [1].  Efforts are therefore made to increase
the accuracy of MRI  in mild or inactive disease. Mild disease
activity can be detected at colonoscopy as superﬁcial ulcerations
of the bowel wall. On standard MR  enterography sequences their
visibility is suboptimal [2] and have a weak agreement when
assessed by multiple observers [3].
Gadolinium is an extracellular contrast agent that rapidly passes
from the vasculature into the extravascular-extracellular space,
resulting in parenchymal enhancement. The increase in signal
intensity of actively diseased bowel is caused by increased vascu-
lar permeability of inﬂammatory tissue, possibly with a positive
correlation between mesenteric hypervascularity/vascular perme-
ability and disease activity. This hypothesis is supported by ﬁndings
by Brahme and Lindström [4] who have shown that the degree
of vascularity is closely related to the intensity of the inﬂamma-
Open access under the Elsevier OA license.tory reaction in surgical specimens of Crohn’s disease. This ﬁnding
is important as analysis of the time-dependent changes of sig-
nal intensity after administration of contrast medium by dynamic
contrast-enhanced MRI  (DCE-MRI) reﬂects the status of tissue
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Fig. 1. Female patient with Crohn’s disease. Superﬁcial ulcerations (mild ulcerative disease) in the terminal ileum at ileocolonoscopy. A. Post contrast 3D T1-weighted
spoiled  gradient echo image shows inﬂamed terminal ileum with homogeneous hyperenhancement and thickened bowel wall. B. ROIs of bowel segments drawn on DCE MRI
sequence (red = terminal ileum, green = coecum and ascending colon, blue = transverse colon, yellow = descending and sigmoid colon). C. ME  map  shows high enhancement
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mred  colour) of terminal ileum. D. Shape map  shows a relative high number of type 
atient  used for determining ME  and ISI. ME  = maximum signal difference/signal ba
icrocirculation and this may  add valuable information about dis-
ase severity, such as the presence of mild ulcerative disease. Earlier
tudies on contrast enhancement of luminal Crohn’s disease have
ither determined enhancement ratios of pathological bowel wall
ersus normal bowel wall [5,6] or subjectively determined the
egree of enhancement (e.g. mild, moderate or marked enhance-
ent) [7].ls in inﬂamed terminal ileum. E. Example of mean TIC of the terminal ileum in this
.
Previous DCE-MRI studies have mainly focused on the presence
of active versus inactive disease [8–11] or used a reference stan-
dard based on clinical symptoms [6].  However, with these methods
no differentiation is possible between the different disease activity
stages necessary for management.
The purpose of this prospective study was to evaluate objec-
tive DCE-MRI parameters for the evaluation of disease severity in
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Fig. 2. Classiﬁcation of TICs. Type 1 (grey): no enhancement; Type 2 (green): slow
enhancement, maximum of the curve is reached after half scan; Type 3 (blue): quick
enhancement, followed by a signal plateau; Type 4 (magenta): fast enhancement andM.L.W. Ziech et al. / European Jou
atients with luminal Crohn’s disease, with an emphasis on mild
lcerative disease.
. Materials and methods
Ethical permission was obtained by the hospitals medical ethics
ommittee and written informed consent was obtained from all
atients.
Forty consecutive patients with known Crohn’s disease who
ere scheduled for ileocolonoscopy and MR  enterography within
 month for assessment of disease activity were prospectively
ncluded from February 2009 to November 2010. Exclusion crite-
ia were age <18 years and contraindications for undergoing MR
maging (such as pacemakers, metallic implants etc.).
.1. MR  imaging protocol
Patients fasted 4 h before the exam and drank 1600 ml  of Man-
itol (2.5%) (Baxter, Utrecht, The Netherlands) 1 h before the scan.
mages were acquired with patients in supine position using a 3-T
R imaging unit (Intera, Philips Healthcare, Best, The Netherlands)
ith a 16-channel torso phased array body coil. The protocol
onsisted of axial and coronal single shot fast spin echo (SSFSE)
equences followed by a coronal fat-saturated SSFSE sequence and
oronal 3D T1-weighted spoiled gradient echo sequence (SPGE)
Table 1). A dynamic coronal 3D T1-weighted fast spoiled gra-
ient echo (FFE) sequence (DCE-MRI sequence) was  performed,
onsisting of 450 consecutive scans with a temporal resolution
f 0.82 s with a spatial resolution of 2.78 mm × 2.78 mm  × 2.5 mm
FOV: 400 mm × 400 mm × 35 mm)  for a total duration of 6 min
nd 11 s. The sequence was performed in free-breathing; patients
ere instructed to breathe regular in a slow frequency. The
D DCE-MRI sequence was conﬁgured with a Cartesian acqui-
ition mode in k-space, the proﬁle order was set to low-high,
 radial turbo direction was used, and in the z-direction the
esolution was doubled during reconstruction. The temporal res-
lution was chosen as high as possible, since we  wanted to
orrect retrospectively for respiratory motion. Therefore, we  used
nterpolation in the z-direction together with a radial readout
ethod. The dynamic volume was placed on the location of visibly
nﬂamed bowel (on SSFSE images) or when absent the termi-
al ileum. When multiple segments were inﬂamed, the sequence
as angulated so all visible inﬂamed segments were in the FOV.
olonoscopy results were not taken into account when placing the
CE-MRI slice. Twenty milligram butylscopalaminebromide (Bus-
opan, Boehringer, Ingelheim, Germany) was given immediately
efore the DCE-MRI sequence and before the post-contrast 3D T1-
eighted spoiled gradient echo sequences. Ten seconds after the
tart of the dynamic sequence 0.1 ml/kg bodyweight of gadobutrol
Gadovist 1.0 mmol/ml, Bayer Schering Pharma, Berlin, Germany)
as injected through a 20 GA intravenous catheter in the antecu-
ital vein by bolus injection (5 ml/s) using an automated injection
ump (Mallinckrodt Optistar, Liebel-Flarsheim, Cincinnati, Ohio,
SA). Injection of contrast medium was immediately followed by a
olus of 15 or 20 ml  saline (5 ml/s), depending on the length of the
ontrast injection tube. After completion of the dynamic sequence
 coronal 3D T1-weighted SPGE (scan parameters identical to pre-
ontrast 3D T1-weighted SPGE) and an axial 3D T1-weighted SPGE
ith fat saturation were acquired..2. Gating and registration
To reduce motion effects in the data, a gating and registration
rocedure was  applied [12] (see Appendix A).quick washout; Type 5 (yellow): quick enhancement, followed by a slow constant
enhancement; Type 6 (red): artery; Type 7 (white/light grey): all others.
2.3. Region of interest (ROI)
The small bowel and the colon were divided into ﬁve segments:
terminal ileum, coecum and ascending colon, transverse colon, and
descending colon and sigmoid in concordance with the Crohn’s
disease endoscopic index of severity (CDEIS), so there could be a
direct segment comparison between MRI  and CDEIS. ROIs were
drawn with ITK-SNAP [13] on the DCE-sequence by a research fel-
low [MZ] on all available slices where the segment was visible. The
ROI included the whole available segment (bowel wall and intralu-
minal contrast). The rectum was  not in the FOV in all patients.
2.4. Analysis of DCE-MRI
We  analyzed the DCE-MRI data in a semi-quantitative fash-
ion. The ﬁrst 300 DCE volumes (=246 s) were used for analysis,
since peristalsis resumed after this period. In each ROI we calcu-
lated the relative maximum enhancement (ME), the initial slope
of increase (ISI) (Fig. 1) and the shape of the time intensity curve
(TIC) on a pixel-by-pixel basis. Seven different curve shapes (six
deﬁned and one undeﬁned shape), automatically classiﬁed accord-
ing to the scheme described by Lavini et al. [14], were each assigned
a unique colour (Fig. 2). The pixel-by-pixel TIC classiﬁcation was
then rendered in a colour-coded map, providing a high resolution
description of the curve shapes in the whole area of interest. We  cal-
culated the total number of pixels classiﬁed for each of the seven
curve shapes, and the relative occurrence of each of these (num-
ber of pixels per shape/total number of pixels in the ROI). Average
values of other semi-quantitative parameters (ME, ISI) were then
calculated across the ROI. These calculations were performed with
home-written software [15].
2.5. Subjective image analysis
Per segment the following features were assessed in consen-
sus by two experienced abdominal radiologists [JS and CYN] with
respectively 17 years (450 MRI  small bowel) and 16 years, (1070
MR small bowel) experience. Quality of distension and visibility
of the bowel wall was  assessed in three categories (insufﬁcient,
sufﬁcient, optimal). Wall thickness was  measured on the SSFSE
sequence using callipers. Mural signal intensity on SSFSE images
was ﬁrst subjectively assessed compared to cerebral spinal ﬂuid
(CSF) signal intensity as no, mild, moderate, or severe high signal
intensity (severe high signal intensity when the bowel wall have a
3022 M.L.W. Ziech et al. / European Journal of Radiology 81 (2012) 3019– 3027
Table  1
Scan parameters at 3T.
Sequences SSFSE SSFSE 3D T1-w SPGE DCE-sequence 3D T1-w SPGE
Direction Axial and coronal Coronal Coronal Coronal Axial
Fat  saturation No Yes Yes No Yes
TR  (ms) 516–758 1370–1450 1.87–2.19 2.9 1.87–2.19
TE  (ms) 65–118 70 1.0 1.8 1.0
Flip  angle (degrees) 90 90 10 6 10
Slice  thickness/gap (mm)  4/1 7/1 – – –
Slices  40 45 100 450 180
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ignal intensity similar as CSF). Although increased signal intensity
f oedematous bowel wall never increases to the signal intensity
f CSF, this is the best parameter to compare because of its high
ater content. The signal intensity was then measured with a ROI
n the bowel wall and a ROI in the CSF; the signal intensity ratio was
alculated (mural T2 signal intensity/CSF signal intensity × 100%).
 stratiﬁed pattern on SSFSE images is thought to be present in
nﬂamed bowel wall with also a ﬁbrous component. The presence
f a stratiﬁcation pattern was scored as layered yes or no.
The bowel wall enhancement was ﬁrst subjectively assessed
s no, mild, moderate or severe pathological enhancement com-
ared to a 3D T1-weighted spoiled gradient echo pre-contrast
equence. Then, a ROI was drawn in the most severely enhanced
art of the segment and on the same site on the pre-contrast
eries. The enhancement ratio was calculated (signal intensity
ost-contrast/pre-contrast × 100%). The enhancement pattern was
ubjectively assessed as layered yes or no.
The presence of ulcerations on any of the sequences was evalu-
ted.
On a per patient basis, the presence of the comb sign
increased mesenteric vascularity), creeping fat (ﬁbrofatty prolifer-
tion around the bowel wall), inﬁltrate, ﬁstula, abscess and stenosis
lumen reduction of >50%) were assessed. The diameter of the
argest intra-abdominal lymph node was measured (short axis)
nd subjective enhancement (pathological enhancement yes/no)
as assessed. The lymph node enhancement ratio was  calculated
signal intensity post-contrast/pre-contrast × 100%).
.6. Reference standards
All patients underwent the hospital’s standard preparation
or ileocolonoscopy. Patients ingested either 4 l of polyethy-
ene glycol electrolyte solution (KleanPrep; Norgine, Amsterdam,
he Netherlands) or 2 l Moviprep (Norgine, Amsterdam, The
etherlands) combined with 2 l tap water for bowel cleans-
ng on the evening before and/or the day of the endoscopy.
he ileocolonoscopy was performed with a standard colonoscope
Olympus CF-Q160AL or CF-Q180AL, Olympus Medical Systems
urope, Hamburg, Germany) by either a gastroenterologist or a
enior resident in gastroenterology under direct supervision of a
astroenterologist. The performing endoscopist was aware of the
atient history, but blinded for the MRI  results.
The CDEIS was determined by one of two gastroenterologists [CP
nd PS] experienced in endoscopy in inﬂammatory bowel disease
during the ileocolonoscopy or on DVD) [16]. CDEIS includes several
arameters: superﬁcial ulcerations, deep ulcerations and the rela-
ive length of bowel affected by these ulcerations or disease activity
n general (this also could be oedema or erythema). These parame-
ers were used to assess disease severity in four categories: normal
ucosa, non-ulcerative lesions, superﬁcial ulcerations (mild ulcer-
tive disease), deep ulcerations (severe ulcerative disease). These
ifferent severities were compared to (DCE-)MRI parameters. A400 ×400 ×200 400 ×400 ×35 400 ×400 × 140
192 × 192 × 100 144 × 144 × 14 208 × 208 × 70
1.5 2 2
segmental CDEIS was  calculated using only the scores of that
segment. Scoring a segmental CDEIS was  performed to enable
more accurate matching between MRI  and endoscopy per seg-
ment. All segments that could be evaluated with ileocolonoscopy
were included in the analysis. In patients where the terminal
ileum could not be intubated, only the colonic segments were
evaluated.
The Crohn’s disease activity index (CDAI) and C-reactive pro-
tein (CRP) were assessed in all patients as secondary reference
standards [17].
2.7. Statistical analysis
Normality of all data was  tested by using normal plots. For
data not normally distributed, medians with interquartile ranges
were determined for descriptive values. Spearman correlation
coefﬁcients were calculated for continuous variables. Correlation
coefﬁcient values were interpreted as follows: 0.0 not correlated;
0.2 weakly correlated; 0.5 moderately correlated; 0.8 strongly cor-
related; 1.0 perfectly correlated. For comparisons between groups
the Mann–Whitney test with Bonferroni adjustment for multiple
testing was used. Association between ordinal subjective param-
eters and CDEIS were assessed by the Chi-2 intraclass correlation.
For comparison of non ulcerative lesions we  excluded the segments
that contained superﬁcial or deep ulcerations as well, as they are
not separately scored in the CDEIS. When comparing disease dura-
tion, with DCE-data only the segment with the highest ME  and ISI
was used. To minimize clustering effect we  used non parametric
testing and give median values.
Statistical analysis was  performed by using software PASW
statistics 18 (Chicago, IL, USA). A p-value <0.05 was considered sta-
tistical signiﬁcant, p < 0.008 for multiple testing between the four
groups.
3. Results
Forty patients were initially included in our study. Seven
patients had to be excluded because of an incomplete refer-
ence standard (three patients), technical failure of dynamic
sequence/MRI (two patients) and negative for Crohn’s disease (two
patients, diagnosis was changed to negative for IBD and ulcerative
colitis based on colonoscopy and pathology results). Thus, 33
patients (mean age 37 years, range 19–72; 23 females) with
histologically proven Crohn’s disease were evaluated. No vasodi-
lating drugs were used by these patients. Twenty-ﬁve patients
(76%) were on Crohn’s disease maintenance therapy. Two patients
used methotrexate (6%), three 5-ASA (9%), 13 purine-antagonists
(39%), six steroids (18%) and 10 anti-tumour necrosis factor (30%).
Sixteen patients (49%) previously underwent an ileocecal resec-
tion. Twenty segments (12%) were of insufﬁcient quality due to
suboptimal distension and/or suboptimal contrast between lumen
and bowel wall to be used for grading. In total 144 (89%) segments
M.L.W. Ziech et al. / European Journal of
Table 2
Correlations between conventional MRI  images and reference parameters (CDEIS).
NS = not signiﬁcant. Categorical variables with linear by linear association, continu-
ous variables with Spearman correlation.
Total number of
segments analyzed
Correlation/association
segmental CDEIS
Wall thicknessa 137 r = 0.418, p < 0.001
Mural signal intensity
SSFSE subjectivea
134 p < 0.001
Mural signal intensity
SSFSE ratioa
134 r = 0.557, p < 0.557
Subjective bowel wall
enhancementa
134 p < 0.001
Enhancement ratioa 123 r = 0.103, p = 0.257
MEb 99 r = 0.485, p < 0.001
ISIb 99 r = 0.206, p = 0.041
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na Based on segments were CDEIS and MRI  parameter was available.
b Based on segments that were included in DCE volume.
ould be evaluated. It was always possible to include all visible
nﬂamed bowel segments in the DCE-ROI. All data except ISI,
nhancement ratio and T2 signal intensity ratio were not normally
istributed.
The median time between colonoscopy and MRI was  8 days (IQR
–16). MRI  and colonoscopy was not performed one the same day.
edian CDEIS was 4.4 (IQR 1.6–6.9). Median segmental CDEIS was
 (IQR 4.5). Median CDAI was 141 (IQR 81–226). Median CRP was  6
IQR 1–22), median disease duration 10 years (6–14).
. Analysis of conventional MRI  data
.1. Per segment data
Wall thickness was weakly correlated with segmental CDEIS
r = 0.418, p < 0.001) (Table 2, Fig. 3). The subjective assessment
f T2 signal intensity was signiﬁcantly associated with segmental
DEIS (p < 0.001), but the T2 signal intensity ratio was  not corre-
ated. Patients with a layered pattern on SSFSE images had a higher
egmental CDEIS (median 4 versus 0, p = 0.014) (Table 3).
Subjective enhancement was signiﬁcantly associated with seg-
ental CDEIS (p < 0.001). The enhancement ratio was not correlated
ith segmental CDEIS. Patients with layered enhancement (12
atients) did not have a signiﬁcantly higher segmental CDEIS
median 0 versus 1, p = 0.093). No ulcerations could be detected
n the conventional sequences. Between the four disease severity
roups T2 SI ratio and T1 enhancement ratio did not differ (Table 4
nd Fig. 4).
ig. 3. Scatterplots. A. Scatterplot of wall thickness and CDEIS per segment shows correla
o  disease activity. B. Scatterplot of ME  and CDEIS per segment shows a correlation of r = Radiology 81 (2012) 3019– 3027 3023
4.2. Per patient data
The comb sign was  present in 15 patients (46%), creeping fat
in 10 patients (30%) and enhancing lymph nodes in 21 patients
(64%). Six patients had an inﬁltrate (18%), 21 a stenosis (64%),
two an intra-abdominal ﬁstula (6%) and one an abscess (3%). In
patients with a comb sign, with a stenosis or where enhanc-
ing lymph nodes were present, CDEIS was signiﬁcantly higher
(p = 0.012, p = 0.004 and p = 0.003, respectively) (Table 3). No dif-
ferences in CDEIS were found between patients with/without the
presence of creeping fat, ﬁstulas, inﬁltrate or abscess. Short axis
diameter of the largest lymph node did not correlate with CDEIS
and CDAI, but with CRP (r = 0.533, p = 0.002). Pathological lymph
node enhancement ratio did not correlate with CDEIS, CDAI and
CRP.
5. Analysis of DCE-MRI
5.1. Per segment data
Median ME  was 0.337 (range 0.223–0.875). Median ISI was
27.5 (range 8.4–57.1). ME  correlated weakly with segmental CDEIS
(r = 0.485, p < 0.001) (Fig. 3), ISI correlated weakly with segmen-
tal CDEIS (r = 0.206, p = 0.041). ME  differed signiﬁcantly between
the four severity groups (p < 0.001); ME  was signiﬁcantly higher in
the mild ulcerative disease and severe ulcerative disease groups
compared to the normal mucosa group (both p < 0.001) (Table 4
and Fig. 4). In addition, wall thickness was  larger in the mild
ulcerative disease group than the normal mucosa group (p < 0.001)
(Fig. 4). ISI did not differ signiﬁcantly between groups, but there
was a trend towards an increase in ISI when disease severity was
higher (Fig. 4). In diseased segments (CDEIS >0) disease dura-
tion correlated with ME  (r = 0.492, p = 0.002). No correlations were
found between TIC curve types and segmental CDEIS. Relative pixel
counts were not signiﬁcantly different in segments with or without
ulcerations.
5.2. Per patient dataMedian ME  was 0.334 (range 0.28–0.45). Median ISI was 29.6
(range 8.7–42.5). ME  was  moderately correlated with total CDEIS
(r = 0.551, p = 0.001), but not with CDAI and CRP. ISI correlated not
with any of the per patient indices.
tion of r = 0.418 (p < 0.001). Data is somewhat skewed due to many segments with
 0.485 (p < 0.001).
3024 M.L.W. Ziech et al. / European Journal of Radiology 81 (2012) 3019– 3027
Table  3
Median values with interquartile ranges for CDEIS, CDEIS per segment. NS = not signiﬁcant.
MRI  feature Present Absent p Value
CDEIS Comb sign 4.8 (4.2–9.0) 1.7 (0.0–5.3) 0.012
Creeping fat 6.1 (4.2–11.1) 4.0 (1.4–5.8) 0.123
Enhancing lymph nodes 5.2 (3.6–10.0) 1.6 (0.0–4.0) 0.003
Fistula 4.3 (3.0–4.3) 4.4 (1.6–7.4) 0.970
Inﬁltrate 4.6 (3.4–7.1) 4.2 (1.6–7.4) 0.454
Abscess 5.6 (5.6–5.6) 4.3 (1.6–7.2) 0.528
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. Discussion
Our results suggest that DCE-MRI can be used for grading
rohn’s disease activity. ME  was signiﬁcantly higher in the mild
lcerative and severe ulcerative disease groups compared to the
ormal mucosa group indicating a higher perfusion in inﬂamed
egments. In addition, a moderate correlation was found between
E and CDEIS, both on a per patient and on a per segment basis
ignifying that ME  can be used to assess disease activity in Crohn’s
isease patients.
Our study had several strengths: we compared the CDEIS per
egment with DCE-MRI data which is more comparable than per
atient indices. In addition, our study comprises the whole disease
ctivity spectrum, with emphasis on mild ulcerative disease activ-
ty (superﬁcial ulcerations) (Fig. 5), in contrast to other studies that
nly compare the presence or absence of disease [8,10,11]. We  used
 pixel by pixel analysis within the ROI to calculate the DCE-MRI
arameters for every individual pixel within the ROI instead of one
E and ISI for the whole ROI. This way variation in DCE-MRI param-
ters can be seen across the whole ROI instead of one speciﬁc point
er segment [9].
An advantage of 3T MRI  compared to lower ﬁeld strengths is
he relatively higher temporal resolution that can be achieved with
igher ﬁeld strength, which gives a curve based on more time
oints. In our study the temporal resolution was 0.82 s. Most other
CE-MRI studies have a relative lower temporal resolution of 3–12 s
8,18] or even larger than 15 s [10,11]. A high temporal resolution
nables a detailed analysis of the contrast uptake. In addition, free
reathing motion artefacts were minimal during our short dynamic
can time.
Several studies found a higher ME  in patients with active
rohn’s disease [6,9–11], although no correlation was found with
 pathology-based reference standard [18]. We  found a moderate
orrelation with segmental CDEIS and a higher ME  in patients with
ild ulcerative and severe ulcerative disease (Fig. 6), corresponding
ith the hypothesis that diseased segments have a larger contrast
ptake. The ulcerations detected at ileocolonoscopy could not be
een on the conventional series, but were detected with DCE-MRI,
able 4
RI  parameters for the different disease severity groups assessed at ileocolonoscopy. NS
Normal mucosa
N = 112
Non ulcerative
lesions
N = 12
Wall thickness (mm)  2 (2–3) 3 (2–3) 
Mural signal intensity SSFSE ratio 33 (24–43) 36 (27–40) 
Enhancement ratio 148 163 
(120–175) (130–192) 
ME 0.304 0.338 
(0.279–0.332) (0.295–0.338)
ISI 27.7 25.0 
(22.5–33.8) (20.4–33.3) 
a Normal mucosa versus mild disease group.
b Normal mucosa versus mild ulcerative disease and normal mucosa versus severe ulce4.8 (3.9–8.3) 1.6 (0.0–3.25) 0.004
24(0–26) 0(0–4) 0.004
1(0–24) 0(0–6) 0.114
which is a relevant ﬁnding given the present limitations in cor-
rectly identifying mild ulcerative disease [1,19].  Low sensitivity
for detecting ulcerations can be due to low spatial resolution [2].
Although median ME  was  higher in segments with non ulcerative
lesions as compared to normal mucosa, this was  not a signiﬁcant
difference. Conceivably further improvements in DCE MRI  proto-
cols can in the future expand this technique.
In comparing the four disease activity groups, there was no
signiﬁcance difference between groups although we  observed a
trend that ISI was higher in segments with worse disease severity
(Fig. 3). Also, segmental CDEIS was  weakly correlated with ISI. In
this case we  might speculate that an increased permeability might
be responsible for this.
We  found a positive correlation of ME  with disease duration
in diseased segments. This was earlier demonstrated in another
study [18]. Our hypothesis is that during longstanding disease
and multiple exacerbations the extravascular space of the bowel
increases which gives rise to increased enhancement. Another
possibility could be that the vascular space is increased due to
neo-angiogenesis. Our data do not support the hypothesis that
patients with longstanding disease have increased permeability as
ISI was not increased in those patients with longstanding disease.
An increased permeability results in easier and faster extravasa-
tion of the contrast agent into the extravascular space, resulting
in a quicker signal enhancement. Further studies need to be per-
formed on the relation between contrast enhancement, acute and
chronic inﬂammation as both disease duration and active current
inﬂammation seem to play a part.
For the conventional MRI  parameters correlations were found
for wall thickness, conﬁrming that this is a parameter can be used
for assessing disease activity as previously reported [20], although
the data is somewhat skewed because of many segments with no
disease activity (Fig. 3). Wall thickness increases not linearly with
increased disease activity. An explanation could be that this might
be due to a ﬁbrous component within the bowel wall after previous
inﬂammation that limits thickening of the bowel wall. This could
also be the explanation for the fact that in our cohort wall thick-
ness was  smaller (though not signiﬁcant) in segments with severe
 = not signiﬁcant. Values are means with IQR.
Mild ulcerative
disease
N = 22
Severe ulcerative
disease
N = 11
p Value
6.5 (2–8) 5.4 (2–9) p < 0.001a
38 (31–46) 32 (22–38) NS
164 144 NS
(110–230) (91–193)
0.378 0.388 p < 0.001b
 (0.323–0.504) (0.339–0.500)
31.7 39.5 NS
(24.1–36.7) (27.1–46.0)
rative disease.
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Fig. 4. Box plots of (DCE-)MRI values (median with IQR) for the four disease severity groups. A. Enhancement ratio. No signiﬁcant differences in enhancement ratios. B. Mural
s was  a 
g iﬁcan
w  the m
d
n
s
n
oignal  intensity SSFSE ratio. No signiﬁcant differences between groups. C. ME.  There 
roup  and the normal mucosa and deep ulcerations group. D. ISI. There was  no sign
ith  disease severity. E. Wall thickness. There was a signiﬁcant difference between
isease activity. Only the subjective assessment of mural T2 sig-
al intensity and enhancement was signiﬁcantly associated with
egmental CDEIS. ROI based measurements did not correlate, thus
o advantage was shown for the use of ROI based measurements
ver the subjective assessment by the radiologist when evaluatingsigniﬁcant difference in ME  between the normal mucosa and superﬁcial ulcerations
t difference between the groups, although a trend was observed that ISI increased
ild ulcerative disease group and normal mucosa group.
conventional MRI  sequences. In addition, ROI based measurements
have a known poor interobserver agreement [21], which can lead
to poor reproducible results.
Our study had some limitations. No optimal reference stan-
dard is available in Crohn’s disease. We chose to adopt CDEIS,
3026 M.L.W. Ziech et al. / European Journal of Radiology 81 (2012) 3019– 3027
Fig. 5. Female 28-year-old patient who previously underwent a ileocecal resection. Colonoscopy showed superﬁcial ulcerations of the neoterminal ileum. A. Coronal SSFSE
images  shows a wall thickness of 3 mm in the neoterminal ileum (arrow). B. Axial post contrast 3D SGE image shows mild enhancement of the neoterminal ileum (arrow).
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sig. 6. Female patient with severe ulcerations in the transverse and ascending colo
olon  (arrow head). B. Axial post contrast 3D SGE image shows moderate enhancem
hich is a colonoscopy based scoring system that grades dis-
ase activity. Only intraluminal lesions can be assessed with
olonoscopy. Other possible reference standards have different
isadvantages: biopsies do not cover the whole segment and
urgical resection specimens are more difﬁcult to obtain as
ost patients receive medical treatment ﬁrst and often concern
ore refractory, ﬁbrotic disease. Nevertheless, in the absence
f more reliable reference standards colonoscopy is the most
avourable.
Another limitation that arose from the study protocol is the
elayed timing of the conventional post contrast sequences. The
uration of the DCE-MRI sequence was 6 min, the 3D T1-weighted
poiled gradient echo sequence was performed thereafter. Because
f this delay in one patient the sequence could not be evalu-
ted as already renal outwash was seen, indicating a too late
valuation of bowel enhancement at the conventional T1-w
equences.
To perform the DCE-sequence with a high temporal resolution
0.82 s) was at the expense of spatial resolution. However, in our
pinion, the spatial resolution of 2.78 mm × 2.78 mm × 2.5 mm was
ufﬁcient for a ROI-based analysis. In addition, our free-breathing
bdominal data required non-rigid registration of the dynamic vol-
mes. We  empirically observed a residual misalignment of 1–2
oxels which we considered sufﬁciently low to justify an ROI-
nalysis. A purely voxel-based approach requires more research
n accurate registration of DCE-MRI data.
Because of technical limitations, the FOV of the DCE volume was
imited to 400 mm × 400 mm × 35 mm.  When placing the ROI our
im was to include all segments as a whole, but the rectum could
ot be included in the FOV in all patients, because of its posterior
osition. In addition, in some segments, parts were outside the FOV,
o could not be included in the DCE-analysis.olonoscopy. A. Axial SSFSE image shows a wall thickness of 3 mm in the transverse
f the transverse and ascending colon (arrow heads).
When performing a per segment analysis (with multiple seg-
ments per patient), a clustering effect could create a bias and this
effect can be adjusted if results are presented as either proportion
(for binomial data) or means (for normal distributed data). We  col-
lected continuous data, but these were not normally distributed
and therefore we used nonparametric testing, resulting in median
values instead of means.
We  did not perform a quantitative DCE-MRI analysis, as had
been done in other studies [8,18].  A quantitative analysis requires
an adequate model, which is very much dependent on several
unknown or chosen parameters such as the arterial input func-
tion, T1 of blood and bowel tissue. In further research, we aim to
accurately determine these parameters.
7. Conclusions
DCE-MRI can be used as a method for detecting Crohn’s disease
lesions, including mild ulcerative disease (superﬁcial ulcerations),
that are often missed on conventional MRI  sequences.
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